Skip to content

Evaluation of clinical curative effect of primary dysmenorrhea with cold coagulation and blood stasis syndrome treated with external characteristics of gynecological characteristics

Evaluation of clinical curative effect of primary dysmenorrhea with cold coagulation and blood stasis syndrome treated with external characteristics of gynecological characteristics

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-17012977
Enrollment
Unknown
Registered
2017-10-14
Start date
2017-10-15
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea with cold coagulation, blood stasis syndrome

Interventions

experimental group:moxibustion, ironing + routine treatment
Control group:Routine treatment

Sponsors

Chengdu University of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Consistent with the diagnostic criteria for primary dysmenorrhea;The syndrome differentiation of Chinese medicine belongs to the syndrome of cold congealing blood stasis;Between the ages of 18~30 years; VAS score 1 to 6; For the past 6 months, there was a history of primary dysmenorrhea for 3 consecutive months, with a menstrual cycle ranging from 21 to 35 days;Informed of the study and signed informed consent.

Exclusion criteria

Exclusion criteria: Allergic constitution; associated with pelvic infection, endometriosis, adenomyosis, myoma of uterus or tumor of reproductive system; Combined with heart, liver, kidney and other important organ dysfunction, digestive and hematopoietic system and other serious diseases, past psychiatric history,disabled persons (blind, deaf, dumb, mental retardation, mental disorder, physical disability) prescribed by law;Planning women for pregnancy, pregnancy or lactation within 6 months, Using a drug intrauterine device; Patients who had been injected or subcutaneously implanted with long-acting contraceptives within 6 months; Patients who take oral contraceptives for less than 8 weeks; Patients who are participating in other clinical trials of drugs. Will not be appropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Degree of dysmenorrhea;Duration of abdominal pain;Gauge;Curative effect of TCM Syndrome;

Countries

China

Contacts

Public ContactLi Ling

Chengdu University of TCM

1050401188@qq.com+8613408000663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026